Erectile dysfunction post radical cystectomy. The role of early rehabilitation with pharmacotherapy in nerve sparing and non-nerve sparing group: A randomized, clinical trial
https://doi.org/10.4081/aiua.2021.1.58
Accepted: October 27, 2020
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Objectives: No clinical studies testing erectile function (EF) post radical cystectomy (RC) were done. Our objective was to assess the effect of early pharmacologic therapy after RC using intracorporeal injection (ICI), phosphodiesterase inhibitor (PDE5i) and PDE5i+ICI.
Materials and Methods: In our randomized, double-blinded study, we prospectively enrolled 160 potent male patients with invasive bladder cancer. Patients were operated by RC using the nerve-sparing (NS) or non-nerve sparing (NNS) technique. They were treated since 1 month postoperatively by different regimens (PDE5i vs. ICI vs. ICI+PDE5i). Patients were evaluated using the international index of erectile function questionnaire and were followed up regularly at 1, 3, 6, and 12 months using the same parameters.
Results: One month after therapy, the mean of EF domain improved in both NS and NNS group. In the NNS group, in patients treated with ICI alone and ICI+PDE5i, the EF domain at 12 months moved to the moderate and to the mild category respectively. In patients treated by the NS approach, the mean value remained in the mild category with or without therapy.
Conclusions: Early pharmacotherapy since one-month post RC using ICI and a combination of ICI+PDE5i can improve the erectile function of patients operated with a NNS approach.
Stein JP, Skinner DG. Results with radical cystectomy for treating bladder cancer: a ‘reference standard’ for high-grade, invasive bladder cancer. BJU Int. 2003; 92:12-7. DOI: https://doi.org/10.1046/j.1464-410X.2003.04274.x
Schlegel PN, Walsh PC. Neuroanatomical approach to radical cystoprostatectomy with preservation of sexual function. J Urol. 1987; 138:1402-6. DOI: https://doi.org/10.1016/S0022-5347(17)43655-X
Miyao N, Adachi H, Sato Y, et al. Recovery of sexual function after nerve-sparing radical prostatectomy or cystectomy. Int J Urol.2001; 8:158-64. DOI: https://doi.org/10.1046/j.1442-2042.2001.00274.x
Rosen RC, Riley A, Wagner G, et al. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997; 49:822-830. DOI: https://doi.org/10.1016/S0090-4295(97)00238-0
Walsh PC, Donker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 1982; 128:492-497. DOI: https://doi.org/10.1016/S0022-5347(17)53012-8
Walsh PC, Mostwin JL. Radical prostatectomy and cystoprostatectomy with preservation of potency. Results using a new nerve-sparing technique. Br J Urol 1984; 56:694-697. DOI: https://doi.org/10.1111/j.1464-410X.1984.tb06149.x
Jacobs BL, Daignault S, Lee CT, et al. Prostate capsule sparing versus nerve sparing radical cystectomy for bladder cancer: results of a randomized, controlled trial. J Urol. 2015; 193:64-70. DOI: https://doi.org/10.1016/j.juro.2014.07.090
Colombo R, Pellucchi F, Moschini M, et al. Fifteen-year singlecentre experience with three different surgical procedures of nervesparing cystectomy in selected organconfined bladder cancer patients. World J Uro.l 2015; 33:1389-95.
Botto H, Sebe P, Molinie V, et al. Prostatic capsule- and seminalsparing cystectomy for bladder carcinoma: initial results for selected patients. BJU Int. 2004; 94:1021-5.
Revelo MP, Cookson MS, Chang SS, et al. Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol. 2004; 171:646. DOI: https://doi.org/10.1097/01.ju.0000107380.40481.bc
Martis G, D'Elia G, Diana M, et al. Prostatic capsule- and nerve-sparing cystectomy in organ-confined bladder cancer: preliminary results. World J Surg. 2005; 29:1277-1281. DOI: https://doi.org/10.1007/s00268-005-7852-7
Horenblas S, Meinhardt W, Ijzerman W, Moonen LF. Sexuality preserving cystectomy and neobladder: initial results. J Urol. 2001;166: 837-840. DOI: https://doi.org/10.1016/S0022-5347(05)65847-8
Schoenberg MP, Walsh PC, Breazeale DR, et al. Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer: 10-year followup. J Urol. 1996; 155:490-494. DOI: https://doi.org/10.1016/S0022-5347(01)66429-2
Bjerre BD, Johansen C, Steven K. Sexological problems after cystectomy: bladder substitution compared with ileal conduit diversion. A questionnaire study of male patients. Scand J Urol Nephrol. 1998; 32:187-193. DOI: https://doi.org/10.1080/003655998750015557
Botto H, Sebe P, Molinie V, et al. Prostatic capsule- and seminal-sparing cystectomy for bladder carcinoma: initial results for selected patients. BJU Int. 2004; 94:1021-1025. DOI: https://doi.org/10.1111/j.1464-410X.2004.05097.x
Kessler TM, Burkhard FC, Perimenis P, et al. Attempted nerve sparing surgery and age have a significant effect on urinary continence and erectile function after radical cystoprostatectomy and ileal orthotopic bladder substitution. J Urol. 2004; 172:1323-1327. DOI: https://doi.org/10.1097/01.ju.0000138249.31644.ec
Fokdal L, Høyer M, Meldgaard P, von der Maase H. Long-term bladder, colorectal, and sexual functions after radical radiotherapy for urinary bladder cancer. Radiother Oncol. 2004; 72:139-145. DOI: https://doi.org/10.1016/j.radonc.2004.05.006
Zippe CD, Raina R, Massanyi EZ, et al. Sexual function after male radical cystectomy in a sexually active population. Urology. 2004; 64:682-685. DOI: https://doi.org/10.1016/j.urology.2004.05.056
Hobisch A, Tosun K, Kinzl J, et al. Quality of life after cystectomy and orthotopic neobladder versus ileal conduit urinary diversion. World J Urol. 2000; 18:338-44. DOI: https://doi.org/10.1007/s003450000147
Zagaja GP, Mhoon DA, Aikens JE, Brendler CB. Sildenafil in the treatment of erectile dysfunction after radical prostatectomy. Urology. 2000; 56: 631-634. DOI: https://doi.org/10.1016/S0090-4295(00)00659-2
Zippe CD, Jhaveri FM, Klein EA, et al. Role of Viagra after radical prostatectomy. Urology. 2000; 55:241-245. DOI: https://doi.org/10.1016/S0090-4295(99)00441-0
User HM, Hairston JH, Zelner D, et al. Penile weight and cell subtype specific changes in a postradical prostatectomy model of erectile dysfunction. J Urol. 2003; 169:1175-1179. DOI: https://doi.org/10.1097/01.ju.0000048974.47461.50
Klein LT, Miller MI, Buttyan R, et al. Apoptosis in the rat penis after penile denervation J Urol. 1997; 158:626-630. DOI: https://doi.org/10.1016/S0022-5347(01)64572-5
R. Wang. Penile rehabilitation after radical prostatectomy: where do we stand and where are we going? J Sex Med. 2007;4:1085-97.
Schwartz EJ, Wong P, Graydon RJ. Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol. 2004; 171:771-4. DOI: https://doi.org/10.1097/01.ju.0000106970.97082.61
La Vignera S, Condorelli R, D'Agata R, et al. Dysfunction of the endothelial-platelet pathway in patients with erectile dysfunction before and after daily treatment with tadalafil. Andrologia. 2012; 44:152-156. DOI: https://doi.org/10.1111/j.1439-0272.2010.01124.x
Gontero P, Fontana F, Bagnasacco A, et al. Is there an optimal timing for intracavernous PGE1 rehabilitation following nonnerve sparing radical prostatectomy Results from an hemodynamic perspective study J Urol. 2003;169:2166-2169. DOI: https://doi.org/10.1097/01.ju.0000064939.04658.15
Montorsi F, Guazzoni G, Strambi LF, et al. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomised trial. J Urol. 1997;158:1408-1410. DOI: https://doi.org/10.1016/S0022-5347(01)64227-7
Padma-Nathan E, Mc Cullough, AR, Giuliano F. Postoperative nightly administration of sildenafil citrate significantly improves the return of normal spontaneous erectile function after bilateral nervesparing radical prostatectomy. J Urol. 2003; 4(Suppl):375.
Klotz L. Cavernosal nerve mapping: current data and applications. British Journal of Urology International. 2004;93:9-13. DOI: https://doi.org/10.1111/j.1464-410X.2004.04546.x
Yuan J, Hoang AN, Romero CA, et al. Vacuum therapy in erectile dysfunction--science and clinical evidence Int J Impot Res. 2010;22:211-9. DOI: https://doi.org/10.1038/ijir.2010.4
Yuan J, Lin H, Li P, et al. Molecular mechanisms of vacuum therapy in penile rehabilitation: a novel animal study. Eur Urol. 2010; 58:773-80. DOI: https://doi.org/10.1016/j.eururo.2010.07.005
Teloken P, Mesquita G, Montorsi F, Mulhall J. Post-radical prostatectomy pharmacological penile rehabilitation: practice patterns among the international society for sexual medicine practitioners. J Sex Med. 2009; 6:2032-8. DOI: https://doi.org/10.1111/j.1743-6109.2009.01269.x
Köhler TS, Pedro R, Hendlin K, et al. A pilot study on the early use of the vacuum erection device after radical retropubic prostatectomy. BJU Int. 2007; 100:858-62. DOI: https://doi.org/10.1111/j.1464-410X.2007.07161.x
Lin H, Wang R. The science of vacuum erectile device in penile rehabilitation after radical prostatectomy. Transl Androl Urol. 2013; 2:61-66.
Saleh A, Abboudi H, Ghazal-Aswad M, et al. Management of erectile dysfunction post-radical prostatectomy. Res Rep Urol. 2015; 7:19-33.
Gallina A, Salonia A, Briganti A, et al. Prevention and management of postprostatectomy erectile dysfunction. Eur Urol Supplements. 2009; 8:80-7. DOI: https://doi.org/10.1016/j.eursup.2008.10.009
Klotz L. Prostate capsule sparing radical cystectomy: oncologic safety and clinical outcome. Ther Adv Urol. 2009; 1:43-50. DOI: https://doi.org/10.1177/1756287209103921
Mertens LS, Meijer RP, de Vries RR, et al. Prostate sparing cystectomy for bladder cancer: 20-year single center experience. J Urol. 2014; 191:1250-5. DOI: https://doi.org/10.1016/j.juro.2013.11.031
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
